Yueping Li
Shihezi University
4 Papers
3 Citations
Yueping Li is an academic researcher from Shihezi University. The author has contributed to research in topics: Systems pharmacology & Cancer. The author has an hindex of 2, co-authored 4 publications.
Chat about Author
Papers
Systems pharmacology uncover the mechanism of anti-non-small cell lung cancer for Hedyotis diffusa Willd.
Xing Su,Yueping Li,Meng Jiang,Jinglin Zhu,Chunli Zheng,Xuetong Chen,Jun Zhou,Yan Li,Yan Li,Wei Xiao,Yonghua Wang,Yonghua Wang +11 more
TL;DR: Results show that HDW treatment of NSCLC may activate immunity, achieve anti-inflammatory, anti-proliferative and anti-migration therapeutic effects by regulating multiple pathways and provides a new idea for understanding the mechanism of TCM.
30
Systems pharmacology reveals the multi-level synergetic mechanism of action of Ginkgo biloba L. leaves for cardiomyopathy treatment.
Yueping Li,Chi Xu,Haiqing Wang,Xiaobing Liu,Li Jiang,Shengnan Liang,Ziyin Wu,Zhenzhong Wang,Jun Zhou,Wei Xiao,Zihu Guo,Yonghua Wang,Yonghua Wang +12 more
TL;DR: Collectively, the multi-level synergetic mechanism of GBLs on cardiomyopathy treatment was demonstrated with systems pharmacology approach, providing a paradigm for deciphering the complicated MoA of TCMs.
24
Systematic Evaluation of the Diagnostic and Prognostic Significance of Competitive Endogenous RNA Networks in Prostate Cancer.
Zihu Guo,Zihu Guo,Liang Han,Yingxue Fu,Ziyin Wu,Yaohua Ma,Yueping Li,Haiqing Wang,Li Jiang,Shengnan Liang,Zhenzhong Wang,Furong Li,Wei Xiao,Jingbo Wang,Yonghua Wang,Yonghua Wang +15 more
TL;DR: A PCa-specific core ceRNA network is constructed, which provides diagnostic and prognostic value and is divided into four novel clinically relevant subgroups with distinct expression patterns, highlighting a feasible way for improving patient stratification in the future.
Synergistic Effect of Network-Based Multicomponent Drugs: An Investigation on the Treatment of Non-Small-Cell Lung Cancer with Compound Liuju Formula.
Xing Su,Meng Jiang,Yueping Li,Jinglin Zhu,Chunli Zheng,Xuetong Chen,Jun Zhou,Wei Xiao,Yonghua Wang,Yonghua Wang,Yan Li,Yan Li +11 more
TL;DR: The systems pharmacology method was applied in this study, which provides a new direction for analyzing the mechanism of TCM, and it was confirmed that the bioactive compounds of compound Liuju formula have not only a killing effect on NSCLC tumor cells but also a synergistic effect on inhibiting the secretion of correlative inflammatory mediators.